Delivery Order SPE2DB22D3016-SPE2DB24FBAT1

Award Date 7/11/24
Potential Completion Date 7/12/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,572.13 for the supply of JANUMET 50-1,000 MG TABLET 60S to the Defense Logistics Agency (DLA). The award has an ultimate completion date of March 24, 2025 and is a Firm Fixed Price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of JANUMET 50-1,000 mg tablets (180 count) to the U.S. government. The contract, valued at $2,068.10, was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for JANUMET 50-1,000 mg tablets. The $3,721.03 firm fixed price delivery order has a completion date of December 4, 2024. The contract is not designated as a set-aside award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,422.04 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $3,184.24 with a completion date of December 24, 2024. The contract was awarded by the Defense Logistics Agency (DLA) and is for the supply of JANUMET 50-1,000 mg tablets. Amerisourcebergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for...
This federal contract award is for the delivery of 4,562,216,924 units of the pharmaceutical product Janumet 50-1,000 mg tablets in 180-count packages. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a firm-fixed-price delivery order valued at $23,132.88, with a period of performance through September 19, 2023. This award is not associated with a set-aside program....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $3,346.65, is for the delivery of the pharmaceutical product JANUMET 50-1,000 MG TABLET 180S. The contract was awarded on July 9, 2024 and has an ultimate completion date of July 10, 2024. This contract is a Delivery Order under a Firm Fixed Price pricing type and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD)....
This is a contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $1,115.08, is for the delivery of Janumet 50-1,000 mg tablets. It is a firm-fixed-price delivery order contract with an ultimate completion date of April 26, 2023. The contract is not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,561.11 delivery order (SPE2DB23FP2E1) is for the supply of 4561680437 JANUMET 50-1,000 mg tablets. The contract has a firm fixed price and an ultimate completion date of August 3, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,419.87 firm fixed-price delivery order is for the supply of Janumet 50-1,000 mg tablets. This contract is a child order under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBAT1
    Delivery Order

This federal contract award is for the delivery of 4,565,122,732 units of JANUMET 50-1,000 mg tablets in 180-count packages, awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA). The $3,554.11 firm fixed-price delivery order contract has a completion date of July 12, 2024.

Amerisourcebergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials, to support the DLA's mission of providing logistics and acquisition services to the U.S. Armed Forces and other government agencies. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.

Generated 10/10/24, 9:03 AM